Literature DB >> 20835832

Head and neck squamous cell cancers: need for an organised time-bound surveillance plan.

Rehan Kazi1, Kapila Manikanthan, K A Pathak, Raghav C Dwivedi.   

Abstract

Optimal care of patients with head and neck squamous cell cancer (HNSCC) involves a pre-determined period of post-treatment follow-up for the detection of recurrent or persistent disease, metastases and second primaries at the earliest opportunity. There is little evidence in literature as to whether the surveillance schemes should be based on patient survival, quality of life or cost-adjusted parameters. This article aims at highlighting some of the issues pertinent to the optimization of surveillance strategies in HNSCC.

Entities:  

Mesh:

Year:  2010        PMID: 20835832     DOI: 10.1007/s00405-010-1377-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  The value of follow-up in patients treated for squamous cell carcinoma of the head and neck.

Authors:  M Boysen; O Lövdal; J Tausjö; F Winther
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer.

Authors:  Frank E Johnson; Michael H Johnson; Marc F Clemente; Randal C Paniello; Katherine S Virgo
Journal:  Ann Surg Oncol       Date:  2006-06-21       Impact factor: 5.344

3.  Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Authors:  Ronan Abgral; Solène Querellou; Gaël Potard; Pierre-Yves Le Roux; Alexandra Le Duc-Pennec; Remi Marianovski; Olivier Pradier; Yves Bizais; Françoise Kraeber-Bodéré; Pierre Y Salaun
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

4.  Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer.

Authors:  K S Virgo; R C Paniello; F E Johnson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-05

Review 5.  Squamous cancer of the head and neck: surgical treatment of local and regional recurrence.

Authors:  J A Ridge
Journal:  Semin Oncol       Date:  1993-10       Impact factor: 4.929

6.  Radiologic appearance of the irradiated larynx. Part II. Primary site response.

Authors:  S K Mukherji; A A Mancuso; I M Kotzur; W M Mendenhall; P S Kubilis; R P Tart; D Freeman; W R Lee
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

7.  Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol.

Authors:  B H Haughey; G A Gates; C L Arfken; J Harvey
Journal:  Ann Otol Rhinol Laryngol       Date:  1992-02       Impact factor: 1.547

8.  Follow-up of head and neck cancer patients post-radiotherapy.

Authors:  William P O'Meara; Jon K Thiringer; Peter A S Johnstone
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

9.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.

Authors:  Heiko Schöder; Henry W D Yeung; Mithat Gonen; Dennis Kraus; Steven M Larson
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

10.  Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer.

Authors:  Oguz Cetinayak; Fadime Akman; Suleyman Kentli; Murat Duzen; Ferhat Eyiler; Mehme Sen; Munir Kinay
Journal:  Tumori       Date:  2008 Jan-Feb
View more
  5 in total

1.  Does the frequency of routine follow-up after curative treatment for head-and-neck cancer affect survival?

Authors:  S F Hall; T Owen; R J Griffiths; K Brennan
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

Review 2.  Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.

Authors:  Antoine Digonnet; Marc Hamoir; Guy Andry; Missak Haigentz; Robert P Takes; Carl E Silver; Dana M Hartl; Primož Strojan; Alessandra Rinaldo; Remco de Bree; Andreas Dietz; Vincent Grégoire; Vinidh Paleri; Johannes A Langendijk; Vincent Vander Poorten; Michael L Hinni; Juan P Rodrigo; Carlos Suárez; William M Mendenhall; Jochen A Werner; Eric M Genden; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-13       Impact factor: 2.503

3.  Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease.

Authors:  H A Wolff; C R M Wolff; C F Hess; K Jung; S Sennhenn-Kirchner; M Hinterthaner; A Müller-Dornieden; W Körber; K Marten-Engelke; R Roedel; H Christiansen; C Engelke
Journal:  Strahlenther Onkol       Date:  2013-07-12       Impact factor: 3.621

4.  Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario.

Authors:  K E Brennan; S F Hall; T E Owen; R J Griffiths; Y Peng
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

5.  Pulmonary Screening Practices of Otolaryngology-Head and Neck Surgeons Across Saudi Arabia in the Posttreatment Surveillance of Squamous Cell Carcinoma: Cross-sectional Survey Study.

Authors:  Majed Alnefaie; Abdullah Alamri; Asalh Saeedi; Awwadh Althobaiti; Yousuf Alqurashi; Hani Marzouki; Mazin Merdad; Shahad Alosaimi
Journal:  Interact J Med Res       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.